clouding, persistent bullous keratopathy, retinal detachment and postoperative
iritis following cataract extraction have been reported.
effects such as flushing, sweating, epigastric distress, abdominal cramps,
urinary bladder, and headache have been reported with
topical or systemic application of carbachol.
The following additional reactions have been identified
during post-approval use of MIOSTAT (carbachol intraocular solution, USP) in
clinical practice. Because they are reported voluntarily from a population of
unknown size, estimates of frequency cannot be made. The reactions, which have
been chosen for inclusion due to either their seriousness, frequency of
reporting, possible causal connection to MIOSTAT, or a combination of these
factors, include: corneal edema, drug effect prolonged (miosis), eye
inflammation, eye pain, intraocular pressure increased, ocular hyperemia,
vision blurred, visual impairment, and vomiting.
No information provided.